Literature DB >> 26683800

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

Nicoletta Colombo1, Carien Creutzberg2, Frederic Amant3, Tjalling Bosse4, Antonio González-Martín5, Jonathan Ledermann6, Christian Marth7, Remi Nout8, Denis Querleu9, Mansoor Raza Mirza10, Cristiana Sessa11.   

Abstract

The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically-relevant questions about endometrial cancer relating to the following four areas: Prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Adjuvant; Consensus; Endometrial neoplasms; Practice guideline; Surgery; Treatment

Mesh:

Year:  2015        PMID: 26683800     DOI: 10.1016/j.radonc.2015.11.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  53 in total

Review 1.  Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

Authors:  Fengjun Guo; Haina Zhang; Zanhui Jia; Manhua Cui; Jingyan Tian
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  Novel Surgical Strategies in the Treatment of Gynecological Malignancies.

Authors:  Martina Aida Angeles; Carlos Martínez-Gómez; Federico Migliorelli; Marie Voglimacci; Justine Figurelli; Stephanie Motton; Yann Tanguy Le Gac; Gwénaël Ferron; Alejandra Martinez
Journal:  Curr Treat Options Oncol       Date:  2018-11-09

3.  Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).

Authors:  Neesha C Dhani; Hal W Hirte; Lisa Wang; Julia V Burnier; Angela Jain; Marcus O Butler; Stephen Welch; Gini F Fleming; Jean Hurteau; Koji Matsuo; Daniela Matei; Waldo Jimenez; Carolyn Johnston; Mihaela Cristea; Katia Tonkin; Prafull Ghatage; Stephanie Lheureux; Anjali Mehta; Judy Quintos; Qian Tan; Suzanne Kamel-Reid; Olga Ludkovski; Ming-Sound Tsao; John J Wright; Amit M Oza
Journal:  Clin Cancer Res       Date:  2020-01-28       Impact factor: 12.531

Review 4.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

5.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

6.  A Prospective Analysis of Laparoscopic Management of Endometrial Cancer in a Tertiary Care Centre.

Authors:  Kavitha Yogini Duraisamy; Malathi Ezhilmani; Devi Balasubramaniam; Kodeeswari Periyasamy
Journal:  J Obstet Gynaecol India       Date:  2021-05-17

7.  Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.

Authors:  Youchun Ye; Hongfeng Li; Jia Bian; Liangfei Wang; Yijie Wang; Hui Huang
Journal:  Int J Gen Med       Date:  2021-11-30

8.  Does ITV vaginal procedure ensure dosimetric coverage during IMRT of post-operative gynaecological tumours without instructions concerning rectal filling?

Authors:  Ramona Verges; Alexandra Giraldo; Alejandro Seoane; Elisabet Toral; M Carmen Ruiz; Ariadna Pons; Jordi Giralt
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-02

9.  Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications?

Authors:  Yaowen Zhang; Carlos Ascaso; Antonio Herreros; Joan Sánchez; Sebastia Sabater; Marta Del Pino; Yan Li; Gabriela Gómez; Aureli Torné; Albert Biete; Ángeles Rovirosa
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-14

10.  Combination Analysis of a Radiomics-Based Predictive Model With Clinical Indicators for the Preoperative Assessment of Histological Grade in Endometrial Carcinoma.

Authors:  Tao Zheng; Linsha Yang; Juan Du; Yanchao Dong; Shuo Wu; Qinglei Shi; Xiaohan Wang; Lanxiang Liu
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.